Cargando…
AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker
To investigate aldo–keto reductase 1C3 (AKR1C3) expression in T and B acute lymphoblastic leukemia/lymphoma (ALL) patients. Three commercial antibodies were evaluated for AKR1C3 immunohistochemistry (IHC) staining performance: Polyclonal Thermofisher scientific (Clone#PA523667), rabbit monoclonal Ab...
Autores principales: | Reddi, Deepti, Seaton, Brandon W., Woolston, David, Aicher, Lauri, Monroe, Luke D., Mao, Zhengwei J., Harrell, Jill C., Radich, Jerald P., Advani, Anjali, Papadantonakis, Nikolaos, Yeung, Cecilia C. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986791/ https://www.ncbi.nlm.nih.gov/pubmed/35388063 http://dx.doi.org/10.1038/s41598-022-09697-6 |
Ejemplares similares
-
Mutational profiling in acute lymphoblastic leukemia by RNA sequencing and chromosomal genomic array testing
por: Yeung, Cecilia, et al.
Publicado: (2021) -
Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts
por: Castaneda Puglianini, Omar, et al.
Publicado: (2020) -
Relapse after Prolonged Remission in Philadelphia-Like Acute Lymphoblastic Leukemia
por: Shah, Gaurav, et al.
Publicado: (2019) -
Management of older adults with acute lymphoblastic leukemia: challenges & current approaches
por: Sawalha, Yazeed, et al.
Publicado: (2018) -
TTMV-RARA fusion as a recurrent cause of AML with APL characteristics
por: Sala-Torra, Olga, et al.
Publicado: (2022)